Loading...
XSHG
688026
, Last price  
Name

Guangzhou Jet Bio-Filtration Co Ltd

Chart & performance

D1W1MN
XSHG:688026 chart
P/E
—
P/S
—
EPS
0.34
Vol. 1Y
—
Shs. 5Y
-0.32%
Rev. 5Y
2.33%
Div Yld LY
—
Div Yld TTM
—
Revenues
565m
+1.20%
70,023,46688,264,749102,787,766124,022,876167,043,100207,479,558247,495,947503,933,836855,658,196609,824,477463,097,581558,657,564565,362,900
Net income
48m
-33.21%
13,555,9268,149,39013,434,01326,072,30540,356,12552,834,86866,153,234119,371,464171,157,97587,712,20634,788,45772,189,56048,212,800
CFO
195m
+260.90%
18,380,06715,665,40013,632,50033,434,20146,670,83245,122,66861,018,800187,566,736221,383,765166,186,158134,806,35353,951,156194,710,889
Dividend
Jul 31, 20260.074 /sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Guangzhou Jet Bio-Filtration Co., Ltd. specializes in the research, development, manufacturing, and global distribution of a diverse range of laboratory products. Their extensive catalog features essential lab consumables like pipettes, tissue culture products, centrifuge tubes, and filtration items, alongside scientific instruments such as analyzers, various lab equipment, reagents, and gloves. The company's reach extends to approximately 50 countries worldwide, serving significant markets including the United States, Japan, Canada, Germany, Australia, and South Korea. Established in 2001, its headquarters are located in Guangzhou, China.
IPO date
Jan 22, 2020
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT